Literature DB >> 34347959

SARS-CoV-2 Variants in Patients with Immunosuppression.

Lawrence Corey1, Chris Beyrer1, Myron S Cohen1, Nelson L Michael1, Trevor Bedford1, Morgane Rolland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34347959      PMCID： PMC8494465          DOI： 10.1056/NEJMsb2104756

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   176.079


× No keyword cloud information.
  13 in total

1.  Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.

Authors:  Brian J Boyarsky; William A Werbel; Robin K Avery; Aaron A R Tobian; Allan B Massie; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  JAMA       Date:  2021-05-04       Impact factor: 56.272

2.  Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.

Authors:  Sung-Youl Ko; Amarendra Pegu; Rebecca S Rudicell; Zhi-yong Yang; M Gordon Joyce; Xuejun Chen; Keyun Wang; Saran Bao; Thomas D Kraemer; Timo Rath; Ming Zeng; Stephen D Schmidt; John-Paul Todd; Scott R Penzak; Kevin O Saunders; Martha C Nason; Ashley T Haase; Srinivas S Rao; Richard S Blumberg; John R Mascola; Gary J Nabel
Journal:  Nature       Date:  2014-08-13       Impact factor: 49.962

3.  Detection of a SARS-CoV-2 variant of concern in South Africa.

Authors:  Houriiyah Tegally; Eduan Wilkinson; Marta Giovanetti; Arash Iranzadeh; Vagner Fonseca; Jennifer Giandhari; Deelan Doolabh; Sureshnee Pillay; Emmanuel James San; Nokukhanya Msomi; Koleka Mlisana; Anne von Gottberg; Sibongile Walaza; Mushal Allam; Arshad Ismail; Thabo Mohale; Allison J Glass; Susan Engelbrecht; Gert Van Zyl; Wolfgang Preiser; Francesco Petruccione; Alex Sigal; Diana Hardie; Gert Marais; Nei-Yuan Hsiao; Stephen Korsman; Mary-Ann Davies; Lynn Tyers; Innocent Mudau; Denis York; Caroline Maslo; Dominique Goedhals; Shareef Abrahams; Oluwakemi Laguda-Akingba; Arghavan Alisoltani-Dehkordi; Adam Godzik; Constantinos Kurt Wibmer; Bryan Trevor Sewell; José Lourenço; Luiz Carlos Junior Alcantara; Sergei L Kosakovsky Pond; Steven Weaver; Darren Martin; Richard J Lessells; Jinal N Bhiman; Carolyn Williamson; Tulio de Oliveira
Journal:  Nature       Date:  2021-03-09       Impact factor: 49.962

4.  SARS-CoV-2 evolution during treatment of chronic infection.

Authors:  Steven A Kemp; Dami A Collier; Rawlings P Datir; Isabella A T M Ferreira; Salma Gayed; Aminu Jahun; Myra Hosmillo; Chloe Rees-Spear; Petra Mlcochova; Ines Ushiro Lumb; David J Roberts; Anita Chandra; Nigel Temperton; Katherine Sharrocks; Elizabeth Blane; Yorgo Modis; Kendra E Leigh; John A G Briggs; Marit J van Gils; Kenneth G C Smith; John R Bradley; Chris Smith; Rainer Doffinger; Lourdes Ceron-Gutierrez; Gabriela Barcenas-Morales; David D Pollock; Richard A Goldstein; Anna Smielewska; Jordan P Skittrall; Theodore Gouliouris; Ian G Goodfellow; Effrossyni Gkrania-Klotsas; Christopher J R Illingworth; Laura E McCoy; Ravindra K Gupta
Journal:  Nature       Date:  2021-02-05       Impact factor: 69.504

5.  Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.

Authors:  Amin Addetia; Katharine H D Crawford; Adam Dingens; Haiying Zhu; Pavitra Roychoudhury; Meei-Li Huang; Keith R Jerome; Jesse D Bloom; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

6.  Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.

Authors:  Tyler N Starr; Allison J Greaney; Amin Addetia; William W Hannon; Manish C Choudhary; Adam S Dingens; Jonathan Z Li; Jesse D Bloom
Journal:  Science       Date:  2021-01-25       Impact factor: 47.728

7.  New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.

Authors:  Salim S Abdool Karim; Tulio de Oliveira
Journal:  N Engl J Med       Date:  2021-03-24       Impact factor: 91.245

8.  Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series.

Authors:  Thao T Truong; Alex Ryutov; Utsav Pandey; Rebecca Yee; Lior Goldberg; Deepa Bhojwani; Paibel Aguayo-Hiraldo; Benjamin A Pinsky; Andrew Pekosz; Lishuang Shen; Scott D Boyd; Oliver F Wirz; Katharina Röltgen; Moiz Bootwalla; Dennis T Maglinte; Dejerianne Ostrow; David Ruble; Jennifer H Han; Jaclyn A Biegel; Maggie Li; ChunHong Huang; Malaya K Sahoo; Pia S Pannaraj; Maurice O'Gorman; Alexander R Judkins; Xiaowu Gai; Jennifer Dien Bard
Journal:  EBioMedicine       Date:  2021-04-26       Impact factor: 8.143

9.  Antibody evasion by the P.1 strain of SARS-CoV-2.

Authors:  Wanwisa Dejnirattisai; Daming Zhou; Piyada Supasa; Chang Liu; Alexander J Mentzer; Helen M Ginn; Yuguang Zhao; Helen M E Duyvesteyn; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Beibei Wang; César López-Camacho; Jose Slon-Campos; Thomas S Walter; Donal Skelly; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M Siqueira; Christina Dold; Robert Levin; Tao Dong; Andrew J Pollard; Julian C Knight; Derrick Crook; Teresa Lambe; Elizabeth Clutterbuck; Sagida Bibi; Amy Flaxman; Mustapha Bittaye; Sandra Belij-Rammerstorfer; Sarah C Gilbert; Miles W Carroll; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Neil G Paterson; Mark A Williams; David R Hall; Ruben J G Hulswit; Thomas A Bowden; Elizabeth E Fry; Juthathip Mongkolsapaya; Jingshan Ren; David I Stuart; Gavin R Screaton
Journal:  Cell       Date:  2021-03-30       Impact factor: 41.582

10.  Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.

Authors:  Victoria A Avanzato; M Jeremiah Matson; Stephanie N Seifert; Rhys Pryce; Brandi N Williamson; Sarah L Anzick; Kent Barbian; Seth D Judson; Elizabeth R Fischer; Craig Martens; Thomas A Bowden; Emmie de Wit; Francis X Riedo; Vincent J Munster
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582
View more
  80 in total

1.  Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?

Authors:  David Baker; Amy MacDougall; Angray S Kang; Klaus Schmierer; Gavin Giovannoni; Ruth Dobson
Journal:  Clin Exp Immunol       Date:  2022-05-12       Impact factor: 4.330

2.  Africa: tackle HIV and COVID-19 together.

Authors:  Nokukhanya Msomi; Richard Lessells; Koleka Mlisana; Tulio de Oliveira
Journal:  Nature       Date:  2021-12       Impact factor: 49.962

3.  How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.

Authors:  Antoni Ribas; Madhav V Dhodapkar; Katie M Campbell; Faith E Davies; Steven D Gore; Ronald Levy; Lee M Greenberger
Journal:  Blood Cancer Discov       Date:  2021-09-15

4.  An early warning system for emerging SARS-CoV-2 variants.

Authors:  Lorenzo Subissi; Anne von Gottberg; Lipi Thukral; Nathalie Worp; Bas B Oude Munnink; Surabhi Rathore; Laith J Abu-Raddad; Ximena Aguilera; Erik Alm; Brett N Archer; Homa Attar Cohen; Amal Barakat; Wendy S Barclay; Jinal N Bhiman; Leon Caly; Meera Chand; Mark Chen; Ann Cullinane; Tulio de Oliveira; Christian Drosten; Julian Druce; Paul Effler; Ihab El Masry; Adama Faye; Simani Gaseitsiwe; Elodie Ghedin; Rebecca Grant; Bart L Haagmans; Belinda L Herring; Shilpa S Iyer; Zyleen Kassamali; Manish Kakkar; Rebecca J Kondor; Juliana A Leite; Yee-Sin Leo; Gabriel M Leung; Marco Marklewitz; Sikhulile Moyo; Jairo Mendez-Rico; Nada M Melhem; Vincent Munster; Karen Nahapetyan; Djin-Ye Oh; Boris I Pavlin; Thomas P Peacock; Malik Peiris; Zhibin Peng; Leo L M Poon; Andrew Rambaut; Jilian Sacks; Yinzhong Shen; Marilda M Siqueira; Sofonias K Tessema; Erik M Volz; Volker Thiel; Sylvie van der Werf; Sylvie Briand; Mark D Perkins; Maria D Van Kerkhove; Marion P G Koopmans; Anurag Agrawal
Journal:  Nat Med       Date:  2022-06       Impact factor: 87.241

Review 5.  COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants.

Authors:  Paola Stefanelli; Giovanni Rezza
Journal:  Vaccines (Basel)       Date:  2022-06-06

6.  Side Effects and Perceptions of COVID-19 Vaccination in Saudi Arabia: A Cross-Sectional Study.

Authors:  Mohammed Khaled Al-Hanawi; Mpho Keetile; Nasser Akeil Kadasah; Noor Alshareef; Ameerah M N Qattan; Omar Alsharqi
Journal:  Front Med (Lausanne)       Date:  2022-06-07

7.  Persistent RNA SARS-CoV-2 Detection in a HIV-Infected Patient.

Authors:  Lucian Giubelan; Ilona Stanciu; Cristina Ilie; Vlad Pădureanu
Journal:  Healthcare (Basel)       Date:  2022-05-25

8.  Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.

Authors:  Karrie K K Ko; Hatairat Yingtaweesittikul; Thuan Tong Tan; Limin Wijaya; Delphine Yanhong Cao; Sui Sin Goh; Nurdyana Binte Abdul Rahman; Kenneth X L Chan; Hui Ming Tay; James Heng Chiak Sim; Kian Sing Chan; Lynette L E Oon; Niranjan Nagarajan; Chayaporn Suphavilai
Journal:  Microbiol Spectr       Date:  2022-05-11

9.  Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022.

Authors:  Slim Fourati; Guillaume Gautier; Myriam Chovelon; Alexandre Soulier; Melissa N'Debi; Vanessa Demontant; Céline Kennel; Christophe Rodriguez; Jean-Michel Pawlotsky
Journal:  Emerg Infect Dis       Date:  2022-05-06       Impact factor: 16.126

10.  Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis.

Authors:  Ohad Yogev; Omer Weissbrod; Giorgia Battistoni; Dario Bressan; Adi Naamti; Ilaria Falciatori; Ahmet C Berkyurek; Roni Rasnic; Myra Hosmillo; Shaul Ilan; Iris Grossman; Lauren McCormick; Christopher C Honeycutt; Timothy Johnston; Matthew Gagne; Daniel C Douek; Ian Goodfellow; Gregory J Hannon; Yaniv Erlich
Journal:  bioRxiv       Date:  2022-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.